| 1 |
35051794 | Vascular cell behavior on glycocalyx-mimetic surfaces: Simultaneous mimicking of the chemical composition and topographical structure of the vascular endothelial glycocalyx. | 2022 Apr |
3 |
| 2 |
35220018 | Targeting angiogenic growth factors using therapeutic glycosaminoglycans on doppel-expressing endothelial cells for blocking angiogenic signaling in cancer. | 2022 Apr |
2 |
| 3 |
34280958 | Structural insights into the modulation of PDGF/PDGFR-β complexation by hyaluronan derivatives. | 2021 Oct 26 |
3 |
| 4 |
33280329 | [Age-related features of the relationship between the content of vascular endothelial growth factor and indicators of lipid metabolism and extracellular matrix metabolism in men in the European part of the Russian Arctic.] | 2020 |
1 |
| 5 |
26478015 | Heparin desulfation modulates VEGF release and angiogenesis in diabetic wounds. | 2015 Dec 28 |
1 |
| 6 |
25016280 | Photopatterning of vascular endothelial growth factor within collagen-glycosaminoglycan scaffolds can induce a spatially confined response in human umbilical vein endothelial cells. | 2014 Nov |
1 |
| 7 |
23734081 | Age-dependent alteration of intraocular soluble heparan sulfate levels and its implications for proliferative diabetic retinopathy. | 2013 |
1 |
| 8 |
20170425 | Development of a porcine bladder acellular matrix with well-preserved extracellular bioactive factors for tissue engineering. | 2010 Oct |
2 |
| 9 |
20524207 | Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activity. | 2010 Oct 1 |
1 |
| 10 |
21171714 | Adhesion, proliferation, and gene expression profile of human umbilical vein endothelial cells cultured on bilayered polyelectrolyte coatings composed of glycosaminoglycans. | 2010 Sep |
1 |
| 11 |
16014624 | A synthetic glycosaminoglycan mimetic binds vascular endothelial growth factor and modulates angiogenesis. | 2005 Sep 23 |
1 |
| 12 |
16283481 | Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo. | 2005 |
1 |
| 13 |
9634701 | Solution structure of the heparin-binding domain of vascular endothelial growth factor. | 1998 May 15 |
1 |
| 14 |
7522446 | Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors. | 1994 Sep 15 |
2 |